Dyphylline and Guaifenesin Oral Solution
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Dyphylline and Guaifenesin Oral Solution contains NLT 90.0% and NMT 110.0% of the labeled amounts of dyphylline (C10H14N4O4) and guaifenesin (C10H14O4)
2 IDENTIFICATION
A. The UV spectra of the major peaks of the Sample solution correspond to those of the Standard solution, as obtained in the Assay.
B. The retention times of the major peaks of the Sample solution correspond to those of the Standard solution, as obtained in the Assay.
3 ASSAY
PROCEDURE
Buffer: 0.01 M monobasic potassium phosphate
Mobile phase: Methanol and Buffer (21:79)
System suitability solution: 0.1 mg/ml. each of USP Guaifenesin RS and USP Dypbylline RS and 0.01 mg/ml. of guaiacol in Mobile phase
Standard solution: 0.1 mg/ml, of USP Guaifenesin RS and 0.1J mg/mt. of USP Dyphylline RS in Mobile phase, J being the ratio of the labeled
amount of dyphylline to that of guaifenesin
Sample solution: Nominally 0.1 mg/ml of guaifenesin, prepared as follows. Transfer 100 mg of guaifenesin from a volume of Oral Solution to a 100-mL volumetric flask, and dilute with Mobile phase to volume. Transfer 5.0 mL of this solution to a 50-mL volumetric flask, and dilute with Mobile phase to volume.
Chromatographic system
(See Chromatography (621), System Suitability)
Mode: LC
Detector: UV 230 nm. For identification test A, use a diode array detector in the range of 200-400 nm.
Columns
Guard: Packing LT
FFIC
Analytical: 4.6-mm 15-cm; packing L1
Flow rate: 2 mL/min
Injection volume: 20 µL
System suitability
Samples: System suitability solution and Standard solution
[NOTE-The relative retention times for dyphylline, guaiacol, and guaifenesin are about 0.25, 0.7, and 1.0, respectively.)
Suitability requirements
Resolution: NLT 1.8 between the guaiacol and guaifenesin peaks, NLT 9.0 between the guaiacol and dyphylline peaks, Systern suitability solution
Relative standard deviation: NMT 2.0% for both dyphylline and guaifenesin, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentages of the labeled amounts of dyphylline (CH, NO) and guaifenesin (C,H,O) in the portion of Oral Solution taken
Result = (rU/(rS) × (CS /CU) x 100
rU = peak response of dyphylline or guaifenesin from the Sample solution
rS = peak response of dyphylline or guaifenesin from the Standard solution
CS = concentration of USP Dyphylline RS or USP Guaifenesin RS in the Standard solution (mg/mL)
CU = Cnominal concentration of dyphylline or guaifenesin in the Sample solution (mg/ml.)
Acceptance criteria: 90.0%-110.0% of the labeled amount of dyphylline (C10H14N4O4) and 90.0%-110.0% of the labeled amount of guaifenesin (C10H14O4)
4 OTHER COMPONENTS
ALCOHOL DETERMINATION Method Ifb (611); 90.0%-110.0% of the labeled amount of alcohol (CHOH)
5 SPECIFIC TESTS
pH(791): 5.0-7.0
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in tight containers.

